1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. IBIO INC
iBio Inc
XNAS: IBIO
1.42 -0.05 (-3.40%)
760.9K
XNAS Volume

XNAS 18 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for iBio Inc

The latest disclosure was made by Marc Banjak in iBio Inc where a trade of 12,500 Common Stock done at an average price of $1.6 was reported to US exchanges on March 26, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Marc Banjak Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 1.64 per share. 26 Mar 2026 12,500 23,566 (0%) 0% 1.6 20,531 Common Stock
Marc Banjak Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 1.76 per share. 26 Mar 2026 1,434 25,000 (0%) 0% 1.8 2,524 Common Stock
Felipe Duran Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.02 per share. 19 Mar 2026 24,835 35,974 (0%) 0% 2.0 50,132 Common Stock
Martin B. Brenner Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.02 per share. 19 Mar 2026 12,336 30,652 (0%) 0% 2.0 24,919 Common Stock
Marc Banjak Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2026 146,000 146,000 - - Stock Option (right to buy)
Felipe Duran Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2026 179,000 179,000 - - Stock Option (right to buy)
Martin B. Brenner Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2026 479,000 479,000 - - Stock Option (right to buy)
William D. Clark Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
Antonio Bernardino Guimaraes Parada Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
Alexandra Kropotova Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
Evert B. Schimmelpennink Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
Gary L. Sender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
David A. Arkowitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2025 13,500 13,500 - - Stock Option (right to buy)
Marc Banjak Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2025 55,000 55,000 - - Stock Option (right to buy)
Felipe Duran Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2025 75,000 75,000 - - Stock Option (right to buy)
Martin B. Brenner Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Oct 2025 180,000 180,000 - - Stock Option (right to buy)
B. Brenner Martin Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 230,700 230,700 - - Stock Option (right to buy)
Duran Felipe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 84,700 84,700 - - Stock Option (right to buy)
Banjak Marc Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 71,000 71,000 - - Stock Option (right to buy)
Antonio Bernardino Guimaraes Parada Director Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 183,823 183,823 (0%) 0% 2.7 499,999 Common Stock
Marc Banjak Chief Legal Officer Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 9,191 11,066 (0%) 0% 2.7 25,000 Common Stock
Felipe Duran Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 9,191 11,139 (0%) 0% 2.7 25,000 Common Stock
Martin B. Brenner Director, See Remarks Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 9,191 18,316 (0%) 0% 2.7 25,000 Common Stock
Gary L. Sender Director Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 9,191 9,191 (0%) 0% 2.7 25,000 Common Stock
David A. Arkowitz Director Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 18,382 18,382 (0%) 0% 2.7 49,999 Common Stock
William D. Clark Director Purchase of securities on an exchange or from another person at price $ 2.72 per share. 10 Jan 2025 1,838 1,838 (0%) 0% 2.7 4,999 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures